LOCAL GUIDELINES FOR DRUG TREATMENT OF PATIENTS WITH COVID-19

LOCAL GUIDELINES FOR DRUG TREATMENT OF PATIENTS WITH COVID-19

  • Slobodan Janković
  • Katarina Pavlović
  • Vladimir Vukićević
  • Jagoda Gavrilović
  • Marko M. Folić
  • Predrag Čanović
  • Ružica Marjanović
  • Slavica Mojsilović
  • Nebojša Stevanović
  • Nikola Rosić

Abstract


Objective. Until now, there have been no guidelines for the use of drugs in patients with COVID 19 in the Republic of Serbia that have been authorized and published in the professional or scientific literature, or on the official websites of the Ministry of Health or health care institutions. The aim of this paper is to present a local guideline for the use of drugs in patients with COVID 19 and the process of its development and adoption.

Methods. The guideline proposal was prepared by a working group based on the results of a systematic search of the medical literature, and quality control of found publications from the category “clinical practice guidelines”. The proposal of the working group was considered and adopted at the sessions of the Drug / Therapeutics Committee and the Quality Assurance Committee of the University Clinical Centre Kragujevac.

Results. The guideline's recommendations are based on the type of patient, and all have the same degree of recommendation and the same quality of evidence on which they are based. Patient types are formed according to the severity of the disease and the need for respiratory support, as well as according to the risk of secondary bacterial infection.

Conclusion. The local guideline to the use of drugs in patients with COVID 19 was developed and adopted in a short period of time, primarily due to the need for its urgent use. Revision of this guide is planned after 6 months from the moment of adoption.

References

Smith AA, Akerson J, Danahey J, Dinh TNM, Porter PS Jr. COVID-19 drive-through testing survey: measuring the burden on healthcare workers. J Am Coll Emerg Physicians Open 2020; Oct 15:10.1002/emp2.12286. (doi: 10.1002/emp2.12286.2).

Wang B, Lai J, Yan X, Jin F, Yi B, An C, et al. COVID-19 Clinical trials registered worldwide for drug intervention: an overview and characteristic analysis. Drug Des Devel Ther 2020; 14: 5097108.

Varshneya M, Irurzun-Arana I, Campana C, Dariolli R, Gutierrez A, Pullinger TK, et al. Investigational treatments for COVID-19 may increase ventricular arrhythmia risk through drug interactions. CPT Pharmacomet Syst Pharmaco 2020; Nov 17. (doi: 10.1002/psp4.125734).

Takla M, Jeevaratnam K. Chloroquine, hydroxychloroquine, and COVID-19: systematic review and narrative synthesis of efficacy and safety. Saudi Pharm J 2020; Nov 13. (doi: 10.1016/j.jsps.2020.11.003).

Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC-C, et al. Infectious Diseases Society of America Guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis 2020; Apr 27: ciaa478. (doi: 10.1093/cid/ciaa478).

COVID-19 rapid guideline: antibiotics for pneumonia in adults in hospital. NICE guideline [NG173]. London: National Institute for Health and Care Excellence, 2020. (https://www.nice.org.uk/guidance/ng173/resources/covid19-rapid-guideline-antibiotics-for-pneumonia-in-adults-in-hospital-pdf-66141959536069).

COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. Bethesda: National Institutes of Health, 2020. (https://www.covid19treatmentguidelines.nih.gov/).

Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Inf Dis 2016; 63: e61-111.

Janković SM. Antiviral therapy of COVID-19. Scr Med 2020; 51: 131–3.

Korona virus COVID-19. Beograd: Ministarstvo zdravlja Republike Srbije, Institut za javno zdravlje Srbije „Dr Milan Jovanović Batut“, 2020. (https://covid19.rs/).

Vaughn VM, Gandhi T, Petty LA, et al. Empiric antibacterial therapy and community-onset bacterial co-infection in patients hospitalized with COVID-19: a multi-hospital cohort study. Clin Infect Dis 2020; Aug 21: ciaa1239. (doi: 10.1093/cid/ciaa1239).

American Academy of Family Physicians. Clinical practice guideline manual. Leawood: American Academy of Family Physicians, 2020. (https://www.aafp.org/family-physician/patient-care/clinical-recommendations/cpg-manual.html).

Published
2020/12/16
Section
Professional Paper